|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 47/61 | (2017.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3870233 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19801630.5 |
| Date of filing the European patent application | 2019-10-23 | |
| (97) | Date of publication of the European application | 2021-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation | 2024-02-26 |
| (86) | Number | PCT/IB2019/059073 |
| Date | 2019-10-23 |
| (87) | Number | WO 2020/084525 |
| Date | 2020-04-30 |
| (30) | Number | Date | Country code |
| 201800009731 | 2018-10-25 | IT |
| (72) |
MOSCONI, Giorgio , IT
JABES, Daniela , IT
PIZZOCARO, Carlo , IT
|
| (73) |
Fidia Farmaceutici S.p.A. ,
Via Ponte della Fabbrica 3/A, 35031 Abano Terme (PD),
IT
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Paklitakselio ir hialurono rūgšties konjugatas, skirtas į raumenis neplintančio šlapimo pūslės vėžio gydymui |
| PACLITAXEL-HYALURONIC ACID CONJUGATE IN THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER |
| Payment date | Validity (years) | Amount | |
| 2025-10-01 | 7 | 162.00 EUR |
| 2026-10-23 |